Lung Function Decline in Male Heavy Smokers Relates to Baseline Airflow Obstruction Severity

Background Recent evidence indicates that the rate of lung function decline is steepest in mild COPD and slower in moderate to severe COPD. The current study assessed whether lung function decline relates to baseline airflow obstruction severity in male heavy smokers. Methods In total, 2,003 male sm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chest 2012-12, Vol.142 (6), p.1530-1538
Hauptverfasser: Mohamed Hoesein, Firdaus A.A., MD, PhD, Zanen, Pieter, MD, PhD, Boezen, H. Marike, PhD, Groen, Harry J.M., MD, PhD, van Ginneken, Bram, PhD, de Jong, Pim A., MD, PhD, Postma, Dirkje S., MD, PhD, Lammers, Jan-Willem J., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1538
container_issue 6
container_start_page 1530
container_title Chest
container_volume 142
creator Mohamed Hoesein, Firdaus A.A., MD, PhD
Zanen, Pieter, MD, PhD
Boezen, H. Marike, PhD
Groen, Harry J.M., MD, PhD
van Ginneken, Bram, PhD
de Jong, Pim A., MD, PhD
Postma, Dirkje S., MD, PhD
Lammers, Jan-Willem J., MD, PhD
description Background Recent evidence indicates that the rate of lung function decline is steepest in mild COPD and slower in moderate to severe COPD. The current study assessed whether lung function decline relates to baseline airflow obstruction severity in male heavy smokers. Methods In total, 2,003 male smokers with a mean (SD) age of 59.8 (5.3) years underwent pulmonary function testing at baseline and after 3-year follow-up. Participants were classified by entry FEV1 /FVC as follows: group 1, >70%; group 2,
doi_str_mv 10.1378/chest.11-2837
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1285467562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0012369212606874</els_id><sourcerecordid>1285467562</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-39800fa00106c5a5eb00c183c6fd614c7691f5e297f7d01df7810974646a586d3</originalsourceid><addsrcrecordid>eNpF0c9P2zAUwHFrGhod47jr5MskLgE_O7GTyyR-rBSpCGmFG5LlOs-bIU3ATor63-PQMk6WpY-frO8j5DuwYxCqPLH_MPbHABkvhfpEJlAJyESRi89kwhjwTMiK75OvMT6wdIdKfiH7nCvOuYAJuZ8P7V86HVrb-66lF2gb3yL1Lb02DdIZmvWGLlbdI4ZI_2Bjeoy07-iZifgmT31wTfdCb5axD8N2ygLXGHy_-Ub2nGkiHu7OA3I3_X17PsvmN5dX56fzzOag-kxUJWPOpN8xaQtT4JIxC6Ww0tUScqtkBa5AXimnaga1UyWwSuUyl6YoZS0OyNF27lPonofUQ698tNg0psVuiBp4WeRSFZInmm2pDV2MAZ1-Cn5lwkYD02NQ_RZUA-gxaPI_dqOH5Qrr__q9YAI_d8BEaxoXTGt9_HBScZZLmdyvrcMUYu0x6LG0T08ecYPxoRtCmxpp0JFrphfj7sbVAZdMlioXrwUMkn8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1285467562</pqid></control><display><type>article</type><title>Lung Function Decline in Male Heavy Smokers Relates to Baseline Airflow Obstruction Severity</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Mohamed Hoesein, Firdaus A.A., MD, PhD ; Zanen, Pieter, MD, PhD ; Boezen, H. Marike, PhD ; Groen, Harry J.M., MD, PhD ; van Ginneken, Bram, PhD ; de Jong, Pim A., MD, PhD ; Postma, Dirkje S., MD, PhD ; Lammers, Jan-Willem J., MD, PhD</creator><creatorcontrib>Mohamed Hoesein, Firdaus A.A., MD, PhD ; Zanen, Pieter, MD, PhD ; Boezen, H. Marike, PhD ; Groen, Harry J.M., MD, PhD ; van Ginneken, Bram, PhD ; de Jong, Pim A., MD, PhD ; Postma, Dirkje S., MD, PhD ; Lammers, Jan-Willem J., MD, PhD</creatorcontrib><description>Background Recent evidence indicates that the rate of lung function decline is steepest in mild COPD and slower in moderate to severe COPD. The current study assessed whether lung function decline relates to baseline airflow obstruction severity in male heavy smokers. Methods In total, 2,003 male smokers with a mean (SD) age of 59.8 (5.3) years underwent pulmonary function testing at baseline and after 3-year follow-up. Participants were classified by entry FEV1 /FVC as follows: group 1, &gt;70%; group 2, &lt;70%, but greater than lower limit of normal (LLN); and group 3, less than LLN. Differences in lung function decline among the groups were assessed using multiple regression after adjustment for pack-years, smoking status (current or former smoker), presence or absence of mucus production, medical center, height, age, CT scan-derived emphysema severity (15th percentile), observation time (years in study), and the baseline values. Results Over 3 years, the mean (SD) FEV1 /FVC, FEV1 , and maximum expiratory flow at 50% of FVC decreases in group 1 were 3.1% (1), 0.21 L (0.07), and 0.40 L/s (0.26), respectively. In group 3, these decreases were 2.4% (1.1), 0.15 L (0.08), and 0.06 L/s (0.19), respectively. All lung function parameters showed the greatest decline in group 1 ( P &lt; .001). Conclusions Diagnosing COPD based on the presence of more severe airflow obstruction (as defined by FEV1 /FVC less than LLN) means that, at the time of such a diagnosis, subjects had passed the phase of strong lung-function decline. Trial registry ISRCTN Register; No.: ISRCTN63545820; URL: www.trialregister.nl</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.11-2837</identifier><identifier>PMID: 22722231</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: American College of Chest Physicians</publisher><subject>Aged ; Airway Obstruction - physiopathology ; Biological and medical sciences ; Cardiology. Vascular system ; Follow-Up Studies ; Forced Expiratory Volume - physiology ; Humans ; Longitudinal Studies ; Lung - physiopathology ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Pulmonary/Respiratory ; Regression Analysis ; Respiratory Function Tests ; Severity of Illness Index ; Smoking - adverse effects ; Vital Capacity - physiology</subject><ispartof>Chest, 2012-12, Vol.142 (6), p.1530-1538</ispartof><rights>The American College of Chest Physicians</rights><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-39800fa00106c5a5eb00c183c6fd614c7691f5e297f7d01df7810974646a586d3</citedby><cites>FETCH-LOGICAL-c417t-39800fa00106c5a5eb00c183c6fd614c7691f5e297f7d01df7810974646a586d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26720466$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22722231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohamed Hoesein, Firdaus A.A., MD, PhD</creatorcontrib><creatorcontrib>Zanen, Pieter, MD, PhD</creatorcontrib><creatorcontrib>Boezen, H. Marike, PhD</creatorcontrib><creatorcontrib>Groen, Harry J.M., MD, PhD</creatorcontrib><creatorcontrib>van Ginneken, Bram, PhD</creatorcontrib><creatorcontrib>de Jong, Pim A., MD, PhD</creatorcontrib><creatorcontrib>Postma, Dirkje S., MD, PhD</creatorcontrib><creatorcontrib>Lammers, Jan-Willem J., MD, PhD</creatorcontrib><title>Lung Function Decline in Male Heavy Smokers Relates to Baseline Airflow Obstruction Severity</title><title>Chest</title><addtitle>Chest</addtitle><description>Background Recent evidence indicates that the rate of lung function decline is steepest in mild COPD and slower in moderate to severe COPD. The current study assessed whether lung function decline relates to baseline airflow obstruction severity in male heavy smokers. Methods In total, 2,003 male smokers with a mean (SD) age of 59.8 (5.3) years underwent pulmonary function testing at baseline and after 3-year follow-up. Participants were classified by entry FEV1 /FVC as follows: group 1, &gt;70%; group 2, &lt;70%, but greater than lower limit of normal (LLN); and group 3, less than LLN. Differences in lung function decline among the groups were assessed using multiple regression after adjustment for pack-years, smoking status (current or former smoker), presence or absence of mucus production, medical center, height, age, CT scan-derived emphysema severity (15th percentile), observation time (years in study), and the baseline values. Results Over 3 years, the mean (SD) FEV1 /FVC, FEV1 , and maximum expiratory flow at 50% of FVC decreases in group 1 were 3.1% (1), 0.21 L (0.07), and 0.40 L/s (0.26), respectively. In group 3, these decreases were 2.4% (1.1), 0.15 L (0.08), and 0.06 L/s (0.19), respectively. All lung function parameters showed the greatest decline in group 1 ( P &lt; .001). Conclusions Diagnosing COPD based on the presence of more severe airflow obstruction (as defined by FEV1 /FVC less than LLN) means that, at the time of such a diagnosis, subjects had passed the phase of strong lung-function decline. Trial registry ISRCTN Register; No.: ISRCTN63545820; URL: www.trialregister.nl</description><subject>Aged</subject><subject>Airway Obstruction - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Follow-Up Studies</subject><subject>Forced Expiratory Volume - physiology</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Lung - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Pulmonary/Respiratory</subject><subject>Regression Analysis</subject><subject>Respiratory Function Tests</subject><subject>Severity of Illness Index</subject><subject>Smoking - adverse effects</subject><subject>Vital Capacity - physiology</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0c9P2zAUwHFrGhod47jr5MskLgE_O7GTyyR-rBSpCGmFG5LlOs-bIU3ATor63-PQMk6WpY-frO8j5DuwYxCqPLH_MPbHABkvhfpEJlAJyESRi89kwhjwTMiK75OvMT6wdIdKfiH7nCvOuYAJuZ8P7V86HVrb-66lF2gb3yL1Lb02DdIZmvWGLlbdI4ZI_2Bjeoy07-iZifgmT31wTfdCb5axD8N2ygLXGHy_-Ub2nGkiHu7OA3I3_X17PsvmN5dX56fzzOag-kxUJWPOpN8xaQtT4JIxC6Ww0tUScqtkBa5AXimnaga1UyWwSuUyl6YoZS0OyNF27lPonofUQ698tNg0psVuiBp4WeRSFZInmm2pDV2MAZ1-Cn5lwkYD02NQ_RZUA-gxaPI_dqOH5Qrr__q9YAI_d8BEaxoXTGt9_HBScZZLmdyvrcMUYu0x6LG0T08ecYPxoRtCmxpp0JFrphfj7sbVAZdMlioXrwUMkn8</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>Mohamed Hoesein, Firdaus A.A., MD, PhD</creator><creator>Zanen, Pieter, MD, PhD</creator><creator>Boezen, H. Marike, PhD</creator><creator>Groen, Harry J.M., MD, PhD</creator><creator>van Ginneken, Bram, PhD</creator><creator>de Jong, Pim A., MD, PhD</creator><creator>Postma, Dirkje S., MD, PhD</creator><creator>Lammers, Jan-Willem J., MD, PhD</creator><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Lung Function Decline in Male Heavy Smokers Relates to Baseline Airflow Obstruction Severity</title><author>Mohamed Hoesein, Firdaus A.A., MD, PhD ; Zanen, Pieter, MD, PhD ; Boezen, H. Marike, PhD ; Groen, Harry J.M., MD, PhD ; van Ginneken, Bram, PhD ; de Jong, Pim A., MD, PhD ; Postma, Dirkje S., MD, PhD ; Lammers, Jan-Willem J., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-39800fa00106c5a5eb00c183c6fd614c7691f5e297f7d01df7810974646a586d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Airway Obstruction - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Follow-Up Studies</topic><topic>Forced Expiratory Volume - physiology</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Lung - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Pulmonary/Respiratory</topic><topic>Regression Analysis</topic><topic>Respiratory Function Tests</topic><topic>Severity of Illness Index</topic><topic>Smoking - adverse effects</topic><topic>Vital Capacity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohamed Hoesein, Firdaus A.A., MD, PhD</creatorcontrib><creatorcontrib>Zanen, Pieter, MD, PhD</creatorcontrib><creatorcontrib>Boezen, H. Marike, PhD</creatorcontrib><creatorcontrib>Groen, Harry J.M., MD, PhD</creatorcontrib><creatorcontrib>van Ginneken, Bram, PhD</creatorcontrib><creatorcontrib>de Jong, Pim A., MD, PhD</creatorcontrib><creatorcontrib>Postma, Dirkje S., MD, PhD</creatorcontrib><creatorcontrib>Lammers, Jan-Willem J., MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohamed Hoesein, Firdaus A.A., MD, PhD</au><au>Zanen, Pieter, MD, PhD</au><au>Boezen, H. Marike, PhD</au><au>Groen, Harry J.M., MD, PhD</au><au>van Ginneken, Bram, PhD</au><au>de Jong, Pim A., MD, PhD</au><au>Postma, Dirkje S., MD, PhD</au><au>Lammers, Jan-Willem J., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lung Function Decline in Male Heavy Smokers Relates to Baseline Airflow Obstruction Severity</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>142</volume><issue>6</issue><spage>1530</spage><epage>1538</epage><pages>1530-1538</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>Background Recent evidence indicates that the rate of lung function decline is steepest in mild COPD and slower in moderate to severe COPD. The current study assessed whether lung function decline relates to baseline airflow obstruction severity in male heavy smokers. Methods In total, 2,003 male smokers with a mean (SD) age of 59.8 (5.3) years underwent pulmonary function testing at baseline and after 3-year follow-up. Participants were classified by entry FEV1 /FVC as follows: group 1, &gt;70%; group 2, &lt;70%, but greater than lower limit of normal (LLN); and group 3, less than LLN. Differences in lung function decline among the groups were assessed using multiple regression after adjustment for pack-years, smoking status (current or former smoker), presence or absence of mucus production, medical center, height, age, CT scan-derived emphysema severity (15th percentile), observation time (years in study), and the baseline values. Results Over 3 years, the mean (SD) FEV1 /FVC, FEV1 , and maximum expiratory flow at 50% of FVC decreases in group 1 were 3.1% (1), 0.21 L (0.07), and 0.40 L/s (0.26), respectively. In group 3, these decreases were 2.4% (1.1), 0.15 L (0.08), and 0.06 L/s (0.19), respectively. All lung function parameters showed the greatest decline in group 1 ( P &lt; .001). Conclusions Diagnosing COPD based on the presence of more severe airflow obstruction (as defined by FEV1 /FVC less than LLN) means that, at the time of such a diagnosis, subjects had passed the phase of strong lung-function decline. Trial registry ISRCTN Register; No.: ISRCTN63545820; URL: www.trialregister.nl</abstract><cop>Northbrook, IL</cop><pub>American College of Chest Physicians</pub><pmid>22722231</pmid><doi>10.1378/chest.11-2837</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-3692
ispartof Chest, 2012-12, Vol.142 (6), p.1530-1538
issn 0012-3692
1931-3543
language eng
recordid cdi_proquest_miscellaneous_1285467562
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Aged
Airway Obstruction - physiopathology
Biological and medical sciences
Cardiology. Vascular system
Follow-Up Studies
Forced Expiratory Volume - physiology
Humans
Longitudinal Studies
Lung - physiopathology
Male
Medical sciences
Middle Aged
Pneumology
Pulmonary/Respiratory
Regression Analysis
Respiratory Function Tests
Severity of Illness Index
Smoking - adverse effects
Vital Capacity - physiology
title Lung Function Decline in Male Heavy Smokers Relates to Baseline Airflow Obstruction Severity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T22%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lung%20Function%20Decline%20in%20Male%20Heavy%20Smokers%20Relates%20to%20Baseline%20Airflow%20Obstruction%20Severity&rft.jtitle=Chest&rft.au=Mohamed%20Hoesein,%20Firdaus%20A.A.,%20MD,%20PhD&rft.date=2012-12-01&rft.volume=142&rft.issue=6&rft.spage=1530&rft.epage=1538&rft.pages=1530-1538&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.11-2837&rft_dat=%3Cproquest_cross%3E1285467562%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1285467562&rft_id=info:pmid/22722231&rft_els_id=1_s2_0_S0012369212606874&rfr_iscdi=true